Immune-related gene expression data of whole blood and spleen from immuno-competent mice implanted with C1498 leukemia cells (AML model) and treated with 5-Azacytidine or Vehicle

Significant differences in gene expression were observed for 5-Azacytidine treated leukemic mice compared to vehicle treated mice during hematologic remission in both spleen and blood samples C57Bl/6 mice were unimplanted and untreated (Healthy), or implanted with C1498 leukemia cells and treated with vehicle (DMSO in diluent) or 5-Azacytidine (AZA) for two complete cycles after which whole blood and spleens were harvested